A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer.
Pignata S, Varriale E, Casella G, Iodice F, De Placido G, Perrone F, Tramontana F, Ricchi P, De Vivo R, Costanzo R, Vernaglia A, Tramontana S.
Pignata S, et al. Among authors: de placido g, de vivo r.
Ann Oncol. 2000 May;11(5):613-6. doi: 10.1023/a:1008344528791.
Ann Oncol. 2000.
PMID: 10907958
Free article.
Clinical Trial.